Interestingly, PrPC expression was found to increase the sensitivity to doxorubicin in MDA-MB-435 breast cancer cells, unlike colorectal cancer, suggesting a tumor type-specific mechanism [71]. This evidence concerns the gene PRNP and breast cancer.